DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th – Mar 26th, 2026)” training has been added to ResearchAndMarketsDUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th – Mar 26th, 2026)” training has been added to ResearchAndMarkets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th – Mar 26th, 2026) – ResearchAndMarkets.com

2025/12/30 01:46
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th – Mar 26th, 2026)” training has been added to ResearchAndMarkets.com’s offering.

The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries.

This seminar will provide a practical overview of the key areas of pharmaceutical regulatory affairs in Asia, including India, and will cover all important aspects of gaining and maintaining a successful marketing authorisation within the region.

The programme will include:

  • Discussion of underlying official regulatory sources
  • An interpretation of practical aspects
  • An overview of the requirements for local manufacturing
  • Recent developments
  • Harmonisation initiatives
  • An update and wider knowledge of regulatory affairs in Asia
  • The opportunity to exchange experiences with other delegate

Benefits of attending:

  • Gain an overview of key Asian markets
  • Discuss outlines of company and product registration
  • Understand the application process
  • Assess the impact of recent regulatory developments in the region
  • Discuss harmonisation initiatives including ASEAN opportunities
  • Understand how Japan fits in the Asian regulatory landscape
  • Discover general, country-specific and regional requirements

Please note that the course will provide an excellent introduction to all the key aspects of regulatory affairs in the Asia region but will not focus specifically or in detail on Chemistry, Manufacture and Control (CMC).

Certifications:

  • CPD: 18 hours for your records
  • Certificate of completion

Who Should Attend:

This programme is primarily designed for Pharmaceutical Regulatory Affairs professionals:

  • Those interested in working with Asian countries, seeking updates on recent developments, exchanging information, or obtaining guidance on current challenges
  • Regulatory Affairs professionals new to the Asian region, requiring extensive background knowledge and training

In addition, the programme may also be of interest to professionals from related functions, such as Marketing, Logistics, Production, and others, who would benefit from a general overview and introduction to Pharmaceutical Regulatory Affairs in Asia.

This programme does not cover Medical Devices, Immunologicals, or Vaccines.

Key Topics Covered:

Day 1

  • Introduction to the Asia Region
  • Introduction to ASEAN
  • Philippines
  • Brunei
  • PR of China

Day 2

  • India
  • Malaysia
  • Singapore
  • Hong Kong
  • Indonesia
  • Thailand
  • Vietnam/Cambodia/Laos

Day 3

  • Taiwan
  • Korea
  • Outline on Japan
  • ASEAN Harmonisation

For more information about this training visit https://www.researchandmarkets.com/r/1v01on

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!